Chemex Pharmaceuticals Inc. announced Friday that Phase IIIclinical trials on the drug Amlexanox for treating canker soreswill begin immediately. Chemex (NASDAQ:CHMX) of Fort Lee,N.J., is developing the anti-inflammatory agent through a jointventure with Block Drug Co. Inc. of Jersey City.

(c) 1997 American Health Consultants. All rights reserved.

No Comments